| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6091302 | Clinical Gastroenterology and Hepatology | 2015 | 6 Pages |
Abstract
Only a small percentage of patients receiving chemotherapy are screened for HBV infection. However, a larger proportion of patients was screened during 2009 to 2011 than during 2006 to 2008, especially patients with hematologic malignancies. Strategies are needed to ensure that patients receiving chemotherapy are protected from the consequences of undiagnosed HBV infection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Chung-Il Wi, Nicole M. Loo, Joseph J. Larson, Timothy J. Moynihan, Nageswar R. Madde, Darryl C. Grendahl, Steven R. Alberts, W. Ray Kim,